These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 21412373)

  • 1. Illicit drug use in the pain patient population decreases with continued drug testing.
    Pesce A; West C; Rosenthal M; Mikel C; West R; Crews B; Almazan P; Latyshev S; Horn PS
    Pain Physician; 2011; 14(2):189-93. PubMed ID: 21412373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled substance abuse and illicit drug use in chronic pain patients: An evaluation of multiple variables.
    Manchikanti L; Cash KA; Damron KS; Manchukonda R; Pampati V; McManus CD
    Pain Physician; 2006 Jul; 9(3):215-25. PubMed ID: 16886030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine drug testing in chronic pain.
    Christo PJ; Manchikanti L; Ruan X; Bottros M; Hansen H; Solanki DR; Jordan AE; Colson J
    Pain Physician; 2011; 14(2):123-43. PubMed ID: 21412368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of the diagnostic accuracy of liquid chromatography-tandem mass spectrometry versus immunoassay drug testing in pain patients.
    Pesce A; Rosenthal M; West R; West C; Crews B; Mikel C; Almazan P; Latyshev S
    Pain Physician; 2010; 13(3):273-81. PubMed ID: 20495592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marijuana correlates with use of other illicit drugs in a pain patient population.
    Pesce A; West C; Rosenthal M; West R; Crews B; Mikel C; Almazan P; Latyshev S; Horn PS
    Pain Physician; 2010; 13(3):283-7. PubMed ID: 20495593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors.
    Gupta A; Patton C; Diskina D; Cheatle M
    Pain Physician; 2011; 14(4):383-9. PubMed ID: 21785482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower Cutoffs for LC-MS/MS Urine Drug Testing Indicates Better Patient Compliance.
    Krock K; Pesce A; Ritz D; Thomas R; Cua A; Rogers R; Lipnick P; Kilbourn K
    Pain Physician; 2017 Nov; 20(7):E1107-E1113. PubMed ID: 29149155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Illicit drug use correlates with negative urine drug test results for prescribed hydrocodone, oxycodone, and morphine.
    Pesce A; West C; Gonzales E; Rosenthal M; West R; Mikel C; Almazan P; Latyshev S; Horn P
    Pain Physician; 2012; 15(5):E687-92. PubMed ID: 22996862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?
    Manchikanti L; Manchukonda R; Pampati V; Damron KS; Brandon DE; Cash KA; McManus CD
    Pain Physician; 2006 Apr; 9(2):123-9. PubMed ID: 16703972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of pain-related medications, metabolites, and illicit substances in urine.
    Gonzales E; Ng G; Pesce A; West C; West R; Mikel C; Latyshev S; Almazan P
    Clin Chim Acta; 2013 Feb; 416():80-5. PubMed ID: 23200822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine toxicology screening among chronic pain patients on opioid therapy: frequency and predictability of abnormal findings.
    Michna E; Jamison RN; Pham LD; Ross EL; Janfaza D; Nedeljkovic SS; Narang S; Palombi D; Wasan AD
    Clin J Pain; 2007 Feb; 23(2):173-9. PubMed ID: 17237667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine specimen detection of concurrent nonprescribed medicinal and illicit drug use in patients prescribed buprenorphine.
    Guo AY; Ma JD; Best BM; Atayee RS
    J Anal Toxicol; 2013; 37(9):636-41. PubMed ID: 24080973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating medicinal from illicit use in positive methamphetamine results in a pain population.
    West R; Pesce A; West C; Mikel C; Velasco J; Gonzales E; Dizon Z; Almazan P; Latyshev S
    J Anal Toxicol; 2013 Mar; 37(2):83-9. PubMed ID: 23316029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of urine drug testing for patients on opioid therapy.
    Pergolizzi J; Pappagallo M; Stauffer J; Gharibo C; Fortner N; De Jesus MN; Brennan MJ; Richmond C; Hussey D;
    Pain Pract; 2010; 10(6):497-507. PubMed ID: 20412503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of urine toxicology in chronic opioid analgesic therapy.
    Compton P
    Pain Manag Nurs; 2007 Dec; 8(4):166-72. PubMed ID: 18036504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of illicit drug use among individuals with chronic pain in the Commonwealth of Kentucky: an evaluation of patterns and trends.
    Manchikanti L; Fellows B; Damron KS; Pampati V; McManus CD
    J Ky Med Assoc; 2005 Feb; 103(2):55-62. PubMed ID: 15751456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical assessment of opioid treatment adherence using urine drug testing in chronic pain management.
    McCarberg BH
    Postgrad Med; 2011 Nov; 123(6):124-31. PubMed ID: 22104461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A validation of self-reported substance use with biochemical testing among patients presenting to the emergency department seeking treatment for backache, headache, and toothache.
    Schuckman H; Hazelett S; Powell C; Steer S
    Subst Use Misuse; 2008; 43(5):589-95. PubMed ID: 18393078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.